Jefferies Group Comments on OraSure Technologies, Inc.’s Q1 2018 Earnings (OSUR)

OraSure Technologies, Inc. (NASDAQ:OSUR) – Investment analysts at Jefferies Group reduced their Q1 2018 earnings per share (EPS) estimates for shares of OraSure Technologies in a report released on Tuesday. Jefferies Group analyst B. Couillard now forecasts that the medical instruments supplier will post earnings of ($0.06) per share for the quarter, down from their prior forecast of $0.07. Jefferies Group has a “Hold” rating on the stock. Jefferies Group also issued estimates for OraSure Technologies’ Q3 2018 earnings at $0.10 EPS, Q4 2018 earnings at $0.20 EPS and FY2019 earnings at $0.52 EPS.

Other analysts also recently issued research reports about the company. Zacks Investment Research raised OraSure Technologies from a “hold” rating to a “buy” rating and set a $23.00 target price on the stock in a research note on Friday, February 9th. Canaccord Genuity reissued a “buy” rating and set a $24.00 target price on shares of OraSure Technologies in a research note on Friday, February 2nd. BidaskClub raised OraSure Technologies from a “hold” rating to a “buy” rating in a research note on Thursday, December 21st. Finally, ValuEngine downgraded OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Thursday, November 2nd. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $22.25.

OraSure Technologies (NASDAQ:OSUR) opened at $17.86 on Thursday. OraSure Technologies has a 12 month low of $10.70 and a 12 month high of $23.01. The company has a market capitalization of $1,048.00, a PE ratio of 35.02, a PEG ratio of 4.82 and a beta of 1.43.

OraSure Technologies (NASDAQ:OSUR) last posted its quarterly earnings data on Wednesday, February 7th. The medical instruments supplier reported $0.12 EPS for the quarter, topping the consensus estimate of $0.11 by $0.01. OraSure Technologies had a return on equity of 13.09% and a net margin of 18.52%. The firm had revenue of $52.00 million for the quarter, compared to the consensus estimate of $50.20 million. During the same quarter last year, the company earned $0.13 earnings per share. The business’s revenue for the quarter was up 46.5% compared to the same quarter last year.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. The Manufacturers Life Insurance Company raised its stake in OraSure Technologies by 3.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 44,672 shares of the medical instruments supplier’s stock valued at $772,000 after purchasing an additional 1,573 shares during the period. Principal Financial Group Inc. raised its stake in OraSure Technologies by 0.7% during the 3rd quarter. Principal Financial Group Inc. now owns 482,574 shares of the medical instruments supplier’s stock valued at $10,858,000 after purchasing an additional 3,531 shares during the period. Teachers Retirement System of The State of Kentucky raised its stake in OraSure Technologies by 24.4% during the 2nd quarter. Teachers Retirement System of The State of Kentucky now owns 19,400 shares of the medical instruments supplier’s stock valued at $335,000 after purchasing an additional 3,800 shares during the period. Rhumbline Advisers raised its stake in OraSure Technologies by 3.9% during the 3rd quarter. Rhumbline Advisers now owns 110,744 shares of the medical instruments supplier’s stock valued at $2,492,000 after purchasing an additional 4,150 shares during the period. Finally, Shelton Capital Management raised its stake in OraSure Technologies by 24.6% during the 4th quarter. Shelton Capital Management now owns 22,826 shares of the medical instruments supplier’s stock valued at $430,000 after purchasing an additional 4,500 shares during the period. 91.62% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Jefferies Group Comments on OraSure Technologies, Inc.’s Q1 2018 Earnings (OSUR)” was posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2018/02/15/jefferies-group-comments-on-orasure-technologies-inc-s-q1-2018-earnings-osur.html.

About OraSure Technologies

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply